Cargando…
Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China
BACKGROUND: As the main cause of cancer death, lung cancer imposes seriously health and economic burdens on individuals, families, and the health system. In China, there is no national study analyzing the hospitalization expenditures of different payment methods by lung cancer inpatients. Based on t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881291/ https://www.ncbi.nlm.nih.gov/pubmed/36703175 http://dx.doi.org/10.1186/s12913-023-09078-3 |
_version_ | 1784879079927840768 |
---|---|
author | Hu, Hanxu Zhao, Liying Yong, Yang Nicholas, Stephen Maitland, Elizabeth Zhao, Weihan Yan, Hao Ma, Yong Shi, Xuefeng |
author_facet | Hu, Hanxu Zhao, Liying Yong, Yang Nicholas, Stephen Maitland, Elizabeth Zhao, Weihan Yan, Hao Ma, Yong Shi, Xuefeng |
author_sort | Hu, Hanxu |
collection | PubMed |
description | BACKGROUND: As the main cause of cancer death, lung cancer imposes seriously health and economic burdens on individuals, families, and the health system. In China, there is no national study analyzing the hospitalization expenditures of different payment methods by lung cancer inpatients. Based on the 2010–2016 database of insured urban resident lung cancer inpatients from the China Medical Insurance Research Association (CHIRA), this paper aims to investigate the characteristics and cost of hospitalized lung cancer patient, to examine the differences in hospital expenses and patient out-of-pocket (OOP) expenses under four medical insurance payment methods: fee-for-service (FFS), per-diem payments, capitation payments (CAP) and case-based payments, and to explore the medical insurance payment method that can be conducive to controlling the cost of lung cancer. METHOD: This is a 2010–2016, 7-year cross-sectional study. CHIRA data are not available to researchers after 2016. The Medical Insurance Database of CHIRA was screened using the international disease classification system to yield 28,200 inpatients diagnosed with lung cancer (ICD-10: C34, C34.0, C34.1, C34.2, C34.3, C34.8, C34.9). The study includes descriptive analysis and regression analysis based on generalized linear models (GLM). RESULTS: The average patient age was 63.4 years and the average length of hospital stay (ALOS) was 14.2 day; 60.7% of patients were from tertiary hospitals; and 45% were insured by FFS. The per-diem payment had the lowest hospital expenses (RMB7496.00/US$1176.87), while CAP had the lowest OOP expenses (RMB1328.18/US$208.52). Compared with FFS hospital expenses, per-diem was 21.3% lower (95% CI = -0.265, -0.215) and case-based payment was 8.4% lower (95% CI = -0.151, -0.024). Compared with the FFS, OOP expenses, per-diem payments were 9.2% lower (95% CI = -0.130, -0.063) and CAP was 15.1% lower (95% CI = -0.151, -0.024). CONCLUSION: For lung cancer patients, per-diem payment generated the lowest hospital expenses, while CAP meant patients bore the lowest OOP costs. Policy makers are suggested to give priority to case-based payments to achieve a tripartite balance among medical insurers, hospitals, and insured members. We also recommend future studies comparing the disparities of various diseases for the cause of different medical insurance schemes. |
format | Online Article Text |
id | pubmed-9881291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98812912023-01-28 Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China Hu, Hanxu Zhao, Liying Yong, Yang Nicholas, Stephen Maitland, Elizabeth Zhao, Weihan Yan, Hao Ma, Yong Shi, Xuefeng BMC Health Serv Res Research BACKGROUND: As the main cause of cancer death, lung cancer imposes seriously health and economic burdens on individuals, families, and the health system. In China, there is no national study analyzing the hospitalization expenditures of different payment methods by lung cancer inpatients. Based on the 2010–2016 database of insured urban resident lung cancer inpatients from the China Medical Insurance Research Association (CHIRA), this paper aims to investigate the characteristics and cost of hospitalized lung cancer patient, to examine the differences in hospital expenses and patient out-of-pocket (OOP) expenses under four medical insurance payment methods: fee-for-service (FFS), per-diem payments, capitation payments (CAP) and case-based payments, and to explore the medical insurance payment method that can be conducive to controlling the cost of lung cancer. METHOD: This is a 2010–2016, 7-year cross-sectional study. CHIRA data are not available to researchers after 2016. The Medical Insurance Database of CHIRA was screened using the international disease classification system to yield 28,200 inpatients diagnosed with lung cancer (ICD-10: C34, C34.0, C34.1, C34.2, C34.3, C34.8, C34.9). The study includes descriptive analysis and regression analysis based on generalized linear models (GLM). RESULTS: The average patient age was 63.4 years and the average length of hospital stay (ALOS) was 14.2 day; 60.7% of patients were from tertiary hospitals; and 45% were insured by FFS. The per-diem payment had the lowest hospital expenses (RMB7496.00/US$1176.87), while CAP had the lowest OOP expenses (RMB1328.18/US$208.52). Compared with FFS hospital expenses, per-diem was 21.3% lower (95% CI = -0.265, -0.215) and case-based payment was 8.4% lower (95% CI = -0.151, -0.024). Compared with the FFS, OOP expenses, per-diem payments were 9.2% lower (95% CI = -0.130, -0.063) and CAP was 15.1% lower (95% CI = -0.151, -0.024). CONCLUSION: For lung cancer patients, per-diem payment generated the lowest hospital expenses, while CAP meant patients bore the lowest OOP costs. Policy makers are suggested to give priority to case-based payments to achieve a tripartite balance among medical insurers, hospitals, and insured members. We also recommend future studies comparing the disparities of various diseases for the cause of different medical insurance schemes. BioMed Central 2023-01-26 /pmc/articles/PMC9881291/ /pubmed/36703175 http://dx.doi.org/10.1186/s12913-023-09078-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hu, Hanxu Zhao, Liying Yong, Yang Nicholas, Stephen Maitland, Elizabeth Zhao, Weihan Yan, Hao Ma, Yong Shi, Xuefeng Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title | Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title_full | Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title_fullStr | Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title_full_unstemmed | Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title_short | Medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban China |
title_sort | medical insurance payment schemes and patient medical expenses: a cross-sectional study of lung cancer patients in urban china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881291/ https://www.ncbi.nlm.nih.gov/pubmed/36703175 http://dx.doi.org/10.1186/s12913-023-09078-3 |
work_keys_str_mv | AT huhanxu medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT zhaoliying medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT yongyang medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT nicholasstephen medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT maitlandelizabeth medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT zhaoweihan medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT yanhao medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT mayong medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina AT shixuefeng medicalinsurancepaymentschemesandpatientmedicalexpensesacrosssectionalstudyoflungcancerpatientsinurbanchina |